According to CONMED's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.29322. At the end of 2023 the company had a P/S ratio of 2.88.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.88 | 11.57% |
2022 | 2.58 | -37% |
2021 | 4.10 | 10.45% |
2020 | 3.71 | 11.61% |
2019 | 3.33 | 58.4% |
2018 | 2.10 | 17.52% |
2017 | 1.79 | 11.07% |
2016 | 1.61 | -5.16% |
2015 | 1.70 | 0.62% |
2014 | 1.69 | 8.9% |
2013 | 1.55 | 49.84% |
2012 | 1.03 | 4.59% |
2011 | 0.9884 | -5.42% |
2010 | 1.05 | 9.25% |
2009 | 0.9566 | 2.19% |
2008 | 0.9361 | -1.75% |
2007 | 0.9528 | -4.75% |
2006 | 1.00 | -7.43% |
2005 | 1.08 | -26.74% |
2004 | 1.47 | 5.86% |
2003 | 1.39 | 12% |
2002 | 1.24 | 5.93% |
2001 | 1.17 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 4.17 | 26.53% | ๐บ๐ธ USA |
![]() Medtronic MDT | 3.52 | 6.98% | ๐ฎ๐ช Ireland |
![]() Boston Scientific BSX | 5.63 | 70.88% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | 5.46 | 65.79% | ๐บ๐ธ USA |
![]() Teleflex TFX | 3.82 | 15.87% | ๐บ๐ธ USA |
![]() Integra LifeSciences IART | 2.02 | -38.77% | ๐บ๐ธ USA |
![]() Smith & Nephew
SNN | 2.85 | -13.32% | ๐ฌ๐ง UK |